Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
MCKESSON CORPORATION |
Delayed
Other stock markets
|
|
5-day change | 1st Jan Change | |
| 434.85 USD | -1.63% | -0.87% | +15.92% | |
| Sep. 07 | McKesson CEO Tyler Sells 3,938 Shares for $1.6 Million | MT |
| Aug. 31 | MCKESSON CORPORATION : Ex-dividend day for | FA |
Financials (USD)
| Sales 2024 * | 305 B | Sales 2025 * | 325 B | Capitalization | 59 632 M |
|---|---|---|---|---|---|
| Net income 2024 * | 3,461 M | Net income 2025 * | 3,642 M | EV / Sales 2024 * | 0,21x |
| Net Debt 2024 * | 3,050 M | Net Debt 2025 * | 4,573 M | EV / Sales 2025 * | 0,20x |
| P/E ratio 2024 * | 17,0x | P/E ratio 2025 * | 15,5x | Employees | - |
| Yield 2024 * | 0,56% | Yield 2025 * | 0,61% | Free-Float | 48.47% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | -0.53% | ||
| 1 week | +0.87% | ||
| Current month | +7.21% | ||
| 1 month | +4.40% | ||
| 3 months | +6.46% | ||
| 6 months | +24.70% | ||
| Current year | +17.84% |
1 week
439.60
446.95
1 month
404.72446.95
Current year
331.75446.95
1 year
331.75446.95
3 years
141.32446.95
5 years
106.11446.95
10 years
106.11446.95
| Managers | Title | Age | Since |
|---|---|---|---|
Brian Tyler
CEO | Chief Executive Officer | 56 | 2019 |
Britt Vitalone
DFI | Director of Finance/CFO | 54 | 2018 |
Nancy Flores
CTO | Chief Tech/Sci/R&D Officer | 57 | 2020 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Brian Tyler
BRD | Director/Board Member | 56 | 2019 |
Maria Martinez
BRD | Director/Board Member | 65 | 2019 |
Donald Knauss
CHM | Chairman | 72 | 2022 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 23-09-29 | 434.85 | -1.63% | 682 085 |
| 23-09-28 | 442.04 | -0.53% | 694,570 |
| 23-09-27 | 444.38 | +0.30% | 953,737 |
| 23-09-26 | 443.03 | -0.76% | 816,562 |
| 23-09-25 | 446.42 | +1.77% | 998,979 |
Delayed Quote Nyse, September 28, 2023 at 04:01 pm EDT
More quotes
McKesson Corporation specializes in pharmaceutical product distribution. The group also offers technological services to healthcare companies. Net sales break down by activity as follows:
- distribution of pharmaceutical products (80.4%);
- distribution of medical and surgical products (4.4%);
- other (1.5%): primarily technology services and software sales.
The remaining sales (13.8%) are from international activities.
Sector
Pharmaceuticals
Calendar
2023-11-01
- Q2 2024 Earnings Release
Trading Rating :
Investor Rating :
ESG Refinitiv :
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
442.04USD
Average target price
474.23USD
Spread / Average Target
+7.28%
EPS Revisions
| 1st Jan change | Capi. (M$) | |
|---|---|---|
| +17.84% | 59 632 M $ | |
| +14.22% | 21 630 M $ | |
| -9.74% | 10 126 M $ | |
| +15.68% | 8 970 M $ | |
| +1.40% | 8 325 M $ | |
| 0.00% | 4 121 M $ | |
| +23.75% | 4 034 M $ | |
| -21.18% | 3 955 M $ | |
| +45.18% | 3 577 M $ | |
| +18.82% | 3 426 M $ |
